
Dabiten 110mg Capsule
Marketer
Alteus Biogenics Pvt Ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabiten 110mg Capsule
CardioGuard 110mg capsules act as a blood thinner, preventing and treating blood clots to lower the risk of stroke and heart attack. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clotting, it also mitigates clot risk post-knee or hip replacement. It can be administered with or without food, ideally at the same time daily. Long-term use, sometimes lifelong, is common; discontinuing or altering dosage without medical supervision significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including diet, exercise, smoking cessation, and weight management, further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding (e.g., nosebleeds, bruising). Report any adverse effects immediately. Other potential side effects comprise headaches, seizures, allergic responses, visual disturbances, and fatigue. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't necessary.
Primary Ingredients of Dabiten 110mg Capsule
No text provided. Please provide the text you wish me to rewrite.
Uses of Dabiten 110mg Capsule
Managing and averting blood clots.
Major Benefits of Dabiten 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabiten 110mg Capsules. These capsules can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dabiten 110mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabiten 110mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabiten 110mg Capsules. These capsules can be ingested with or without food; however, consistent daily timing is recommended.
How Dabiten 110mg Capsule works:
Xarelto 110mg capsules represent a new class of oral blood thinners. Their mechanism of action involves inhibiting clot development within the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dabiten 110mg Capsules with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Dabiten 110mg capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dabiten 110mg capsules while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabiten 110mg Capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabiten 110mg Capsules, potentially requiring dosage modification. A physician's consultation is advised. Dabiten 110mg Capsules are contraindicated in patients with severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should exercise caution when using Dabiten 110mg Capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dabiten 110mg Capsule :
Should you forget to take your Dabiten 110mg Capsule, ingest it immediately upon recollection, provided it remains the same day. However, omit the missed dose if it's impossible to administer it at least six hours prior to your next planned dose. Never compensate for a missed dose by taking double the prescribed amount.
Facts to Know About Dabiten 110mg Capsule
| Label | Value |
|---|---|
| Type of Compound | Benzimiidazole-based compound |
| Potential for Dependence | None. |
| Type of Treatment | HEART |
| Mechanism of Action | Thrombin inhibitor for oral administration |
